Edition:
United Kingdom

Novus Therapeutics Inc (NVUS.OQ)

NVUS.OQ on NASDAQ Stock Exchange Capital Market

3.03USD
6:27pm GMT
Change (% chg)

$0.22 (+7.65%)
Prev Close
$2.81
Open
$2.81
Day's High
$3.15
Day's Low
$2.81
Volume
2,215
Avg. Vol
22,819
52-wk High
$8.61
52-wk Low
$2.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.371
Jun '18 0.00 -0.339
Mar '18 0.00 -0.362
FY 2017 Dec '17 0.00 -0.294
Sep '17 0.00 -0.428
Jun '17 0.00 -1.603
Mar '17 0.00 -0.428
FY 2016 Dec '16 0.00 -1.485
Sep '16 0.00 -3.686
Jun '16 0.00 -5.378
Mar '16 0.00 -4.545
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 2 0.00 0.00 0.00 --
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Dec-18 2 0.00 0.00 0.00 --
Year Ending Dec-19 2 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Dec-18 2 -0.40 -0.38 -0.42 --
Quarter Ending Mar-19 2 -0.40 -0.38 -0.41 --
Year Ending Dec-18 2 -1.47 -1.45 -1.49 --
Year Ending Dec-19 2 -1.41 -1.23 -1.59 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.13 34.39
P/E High - Last 5 Yrs. -- 40.59 46.24
P/E Low - Last 5 Yrs. -- 23.99 24.59
Beta -- 0.91 0.91
Price to Sales (TTM) -- 4.00 6.22
Price to Book (MRQ) 1.43 5.02 5.20
Price to Tangible Book (MRQ) 1.55 5.76 6.74
Price to Cash Flow (TTM) -- 23.20 24.17
% Owned Institutions 52.52 0.95 1.78

Dividends

  Company industry sector
Dividend Yield -- 1.55 1.44
Dividend Yield - 5 Year Avg -- 1.56 1.46
Dividend 5 Year Growth Rate -- 4.21 4.94
Payout Ratio(TTM) -- 45.68 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.33 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 4.80 6.50
Sales - 5 Yr. Growth Rate -- 10.00 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 70.19 17.26 23.08
EPS (TTM) vs TTM 1 Yr. Ago 62.18 -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.49
Capital Spending - 5 Yr. Growth Rate -- 15.23 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.20 2.28
Current Ratio (MRQ) 7.86 3.02 3.10
LT Debt to Equity (MRQ) 1.05 8.89 11.49
Total Debt to Equity (MRQ) 1.05 12.69 16.03
Interest Coverage (TTM) -- 35.18 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.41 54.44
Gross Margin - 5 Yr. Avg. -- 51.86 52.36
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.41 13.16
Operating Margin (TTM) -- 14.42 6.07
Operating Margin - 5 Yr. Avg. -- 14.55 8.47
Pre-Tax Margin (TTM) -- 14.96 7.02
Pre-Tax Margin - 5 Yr. Avg. -- 14.97 8.71
Net Profit Margin (TTM) -- 11.16 3.12
Net Profit Margin - 5 Yr. Avg. -- 11.23 4.91
Effective Tax Rate (TTM) -- 23.45 23.26
Effective Tax Rate - 5 Yr. Avg. -- 23.65 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 997,012,430 873,053,182
Net Income/Employee (TTM) -2,630,375 118,232,500 103,483,965
Receivable Turnover (TTM) -- 5.82 5.80
Inventory Turnover (TTM) -- 2.68 3.56
Asset Turnover (TTM) 0.00 0.99 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -57.10 11.98 11.45
Return on Assets - 5 Yr. Avg. -- 13.28 12.50
Return on Investment (TTM) -67.10 15.55 14.96
Return on Investment - 5 Yr. Avg. -- 17.28 16.23
Return on Equity (TTM) -67.53 16.92 16.52
Return on Equity - 5 Yr. Avg. -- 18.21 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 16.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Novus Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.90%
# of Holders: 32
Total Shares Held: 4,984,086
3 Mo. Net Change: 3,093
# New Positions: 6
# Closed Positions: 2
# Increased Positions: 15
# Reduced Positions: 7
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.